Abd-Elsayed, Alaa
Matta, Andrew Y.
Nitz, James N.
Henjum, Lukas J.
Shiferaw, Barnabas T.
May, Raven
Fiala, Kenneth J.
Article History
Received: 29 December 2023
Accepted: 30 April 2024
First Online: 27 May 2024
Declarations
:
: Alaa Abd-Elsayed is an Editorial Board member of <i>Advances in Therapy and a consultant of Avanos</i>. Alaa Abd-Elsayed was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The other authors (Andrew Y Matta, James N Nitz, Lukas J Henjum, Barnabas T Shiferaw, Kenneth J Fiala and Raven May) declare no conflict of interest.
: Institutional review board (IRB) application submitted to the University of Wisconsin IRB and minimal risk research exemption was granted owing to the study’s retrospective nature and lack of contact with the subjects in the study. Compliance with patient confidentiality was maintained throughout the study.